ProCE Banner Activity

CE / CME

People of Childbearing Potential and Their Infants: Overcoming HBV Barriers

Video

Hear patient and faculty insights as they discuss overcoming barriers to effective HBV care for people of childbearing potential and their infants, including HBV screening and vaccination during pregnancy, management of HBV in pregnant people, and postpartum considerations related to infant care and breastfeeding.

Pharmacists: 0.75 contact hour (0.075 CEUs)

Nurses: 0.75 Nursing contact hour

Physicians: Maximum of 0.75 AMA PRA Category 1 Credit

Released: August 16, 2023

Expiration: August 15, 2024

Share

Faculty

Joseph Ahn

Joseph Ahn, MD, MS, MBA

Professor of Medicine
Section Head of Hepatology
Oregon Health and Science University

Alice Chan

Alice Chan

Patient

Christina Delacruz Leyson

Christina Delacruz Leyson, MD

Associate Professor
Medical Director, Liver Transplant Program
Program Director, Hepatology Fellowship
University of Kentucky
Lexington, Kentucky

Provided by

Provided by Clinical Care Options, LLC, in partnership with Hepatitis B Foundation and Asian Health Foundation (AHF)

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

AHF

ProCE Banner

Hepatitis B Foundation

ProCE Banner

Target Audience

This program is intended for physicians, pharmacists, nurses, and other HCPs who care for patients with HBV.

Program Learning Goal

The goal of this activity is to improve learners’ competence in overcoming unique barriers to implementation of optimized HBV care in key communities.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recognize barriers that hamper engagement across the HBV care continuum for people of childbearing potential and their infants, including screening, treatment initiation, monitoring, and sustained therapy.

  • Implement best practices in HBV management for childbearing people and their infants.

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Joseph Ahn, MD, MS, MBA

Professor of Medicine
Section Head of Hepatology
Oregon Health and Science University

Joseph Ahn, MD, MS, MBA: consultant/advisor/speaker: Gilead sciences.

Alice Chan,

Patient

Alice Chan, has no relevant financial relationships to disclose.

Christina Delacruz Leyson, MD

Associate Professor
Medical Director, Liver Transplant Program
Program Director, Hepatology Fellowship
University of Kentucky
Lexington, Kentucky

Christina Delacruz Leyson, MD, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC, Asian Health Foundation, and Hepatitis B Foundation have no relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from August 16, 2023, through August 15, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page
  2. Read the target audience, learning objectives, and faculty disclosures
  3. View and study the content in its entirety
  4. Submit answers to the post-test questions and evaluation questions online

You must receive a test score of at least 65 or above and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint Accreditation
In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO), Asian Health Foundation, and Hepatitis B Foundation. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.00 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number -   JA4008176-9999-23-206-H01-P 

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.